Studies on sustained-release formulations explore how the drug is optimized for patient use.

For technical data regarding its chemical analysis, papers such as the RP-UPLC method for determining impurities provide detailed chromatographic profiles.

Research on the safety and efficacy of Ranolazine for chronic stable angina highlights its unique mechanism as a late sodium current inhibitor.

Based on similar pharmaceutical nomenclature, "Ranoranilac" is likely a misspelling of Ranolazine , a medication used to treat chronic angina. If you are looking for research related to this drug, several prominent studies and reviews are available: